Overview
Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects
Status:
Suspended
Suspended
Trial end date:
2009-09-01
2009-09-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this study is to evaluate the effect of repeated doses of AZD7325 on the pharmacokinetics of ORTHO-CYCLEN, a monophasic oral contraceptivePhase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
AstraZenecaTreatments:
Contraceptive Agents
Contraceptives, Oral
Criteria
Inclusion Criteria:- If previously pregnant, must be > 6 month post-partum at the time of randomization
- Body Mass Index (BMI) greater than or equal to 18 and less than or equal to 30 kg/m2
Exclusion Criteria:
- Use of any prescription medication within 14 days of screening
- current smoker or history of smoking within the last 3 months prior to enrollment
- Abnormal pap smear exam result within one year of enrollment.